|
1. Wang, H.,C. and Paior, R.L.(1997). Oxygen radical absorbing capacity
of fruits. J. Agric.food chem. 45, 304-309.
2. Clifford, M. N. (2000). Review anthocyanins-nature, occurrence and
dietary burden. J. Sci. Food Agric. 80, 1063-1072.
3. Hayashi, K., Ohara, N. and Tsukui, A. (1996) Stability of anthocyanins
in various vegetables and fruits. Food Sci. Technol. Int. 2, 30-33.
4. Steinberg, D., and Witztum, J.L. (1999). Lipoproteins, Lipoprotein, Oxidation, and Atherogenesis, K.R. Chien, ed. (Philadelphia: W.B.
Saunders Co.).
5. Paglia DE, Valentine WN. Studies on the quantitative and qualitative
characterization of erythrocyte glutathione peroxidase. J Lab Clin
Med 1967; 70: 158-169.
6. Jihong H., David P. H., Maria F., and Andrew C. N.(1997)Native and
Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36.
J.Biol.Chem.Vol.272,No34,21654-21659.
7. Weinberg RA. (1995)The retinoblastoma protein and cell cycle control. [Review] [80 refs] Cell, 81 (3): 323-30.
8. Hundal R. S., Salh, B. S., Schrader, J. W., et al. (2001). Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI3-kinase/PKB pathway. Journal of Lipid Research , 42, 1483-1491.
9. Baoutina, A., Dean, R. T., & Jessup, W. (2001). Antioxidant properties of macrophages toward low-density lipoprotein. Trends Cardiovasc Med., 11, 1-7.
10.Colles, S.M., Irwin, K.C., and Chisolm, G.M. (1996). Roles of multiple oxidized lipids in cellular injury. J. Lipid Res. 37, 2018—2028.
11. Bennet, M.R. (1999). Apoptosis of vascular smooth muscle cells in
vascular remodelling and atherosclerotic plaquerupture.Cardiovascular Res. 41, 361—368.
12. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., andWitztum,J.L. (1989). Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320,915—924.
13. Navab, M., Berliner, J.A., Watson, A.D., Hama, S.Y., Territo, M.C.,
Lusis, A.J., Shih, D.M., Van Lenten, B.J., Frank, J.S., Demer, L.L.,
et al. (1996). The yin and yang of oxidation in the development of
the fatty streak. Arterioscler. Thromb. Vasc. Biol. 16, 831—842.
14. Yamada, Y., Doi, T., Hamakubo, T., and Kodama, T. (1998).Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. Life .54,628—640.
15.Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A., and Evans, R.M.(1998). PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241—252.
16. Ross, R. (1999). Atherosclerosis─an inflammatory disease. N. Eng.
J. Med 340, 115—126.
17. Goldstein, J.L., and Brown, M.S. (1977). The low-density lipoprotein
pathway and its relation to atherosclerosis. Ann. Review Biochem.
46, 897—930.
18. Caligiuri, G., Levy, B., Pernow, J., Thoren, P., and Hansson, G.K.
(1999). Myocardial infarction mediated by endothelin receptor sig- naling in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 96,
6920—6924.
19. Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix de-
grading activity in vulnerable regions of human atherosclerotic
plaques. J. Clin. Invest. 94, 2493—2503.
20. Carmeliet, P. (2000). Proteins in cardiovascular aneurysms andrupture: targets for therapy? J. Clin. Invest. 105, 1519—1520.
21.Jha, P., Flather, M., Lonn, E., Farkouh, M., and Yusuf, S. (1995). The
antioxidant vitamins and cardiovascular disease. A critical review of
epidemiologic and clinical trial data. Ann. Intern. Med. 123, 860—872.
Jiang, C., Ting, A.T., and Seed, B. (1998). PPAR-gamma agonists
inhibit production of monocyte inflammatory cytokines. Nature 391,
82—86.
22. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. (2000).
Vitamin E supplementation and cardiovascular events in high-risk
patients. The Heart Outcomes Prevention Evalulation Study Investigators.N. Engl. J. Med. 342, 154—160.
23. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage,K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al.
(1997). A role for macrophage scavenger receptors in atherosclerosis
and susceptibility to infection. Nature 386, 292—296.
24. Febraio, M., Podrez, E.A., Smith, J.D., Hajjar, D.P., Hazen, S.L., Hoff,H.F., Sharma, K., and Silverstein, R.L. (2000). Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049—1056.
25. Toscano, M. A. and Lamonica, G.（1975）Pigments from Morus nigra fruits. Chem.Abstr. 83,55669.
26. Thanka, T., Kawamori, T., Ohnishi, M., Okamoto, M., Mori, H. and Hara, A. (1994) Chemoprevention of 4-nitroquinoline-1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and post-initiation phase. Cancer. Res., 54, 1359-2365
27. Rankin, S.M., De Whalley, C.V., Hoult, R.S., Jessup, W., Wilkins, G.M., Collard, T. and Leake, D.S. (1993) The modification of low density lipoprotein by the flavonoids muricetin and gossypetin. Biochem. Pharmacol., 45, 67-75.
28. De Whalley, C.V., Rankin, S.M., Hoult, J.R., essup, W. and Leake, D.S. (1990) Flavonids inhibit the oxidative modification of low density lipoproetins by macrophages. Biochem. Pharmacol., 39, 1743-1750.
29. Thanka, T., Kojima, T., Kawamori, T., Yoshimi, N. and Mori, H. (1993) Chemoprevention of diethylnitrosamine-inducedhepatocarcinogenesis by a simple phenolic acid, protocatechuic acid in rat. Cancer Res., 53, 2775-2779.
30.Yagi K.( 1987 ) Lipid peroxidation and human diease. Chem. Phy. Lipids., 45:337-51.
31.Bradford M. M.( 1976 ) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-54.
32.Ursim F., Maiorino M.( 1994 ) A novel antioxidant flavonid(IdB1031) affecting molecular mechanisms of cellular activation. Free radical Biology & Medicine. 10: 547-53.
33.Alley M.C.( 1988 )Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48 : 589-92.
34. H. Y. Hsu (2000) Tumor Necrosis Factor-α-mediated Protein Kinases in Regulation of Scavenger Receptor and Foam Cell Formation on Macrophage. J.Biol.Chem.Vol.275,No52,41035-41048.
35. Ajay Chawla, William A.（2001）A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis. Molecular cell.Vol.7,161-171.
36. Ferns, G. A. A., Lamb, D. J. and Taylor, A. 1997. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 133: 139-152.
37.M Freeman, Y Ekkel, L Rohrer, M Penman, NJ Freedman, GM Chisholm, and M Krieger（1991） Expression of Type I and Type II Bovine Scavenger Receptors in Chinese Hamster Ovary Cells: Lipid Droplet Accumulation and Nonreciprocal Cross Competition by Acetylated and Oxidized Low Density Lipoprotein. PNAS.USA 88: 4931-4935.
38. GR Sambrano, S Parthasarathy, and D Steinberg （1994） Recognition of Oxidatively Damaged Erythrocytes by a Macrophage Receptor with Specificity for Oxidized Low Density Lipoprotein. PNAS.USA ,91: 3265-3269.
39. Heinecke, J.W. (1998). Oxidants and antioxidants in the pathogene-
sis of atherosclerosis: implications for the oxidized low density lipo-
protein hypothesis. Atherosclerosis ,141, 1—15.
40. Steinberg, D., and Witztum, J.L. (1999). Lipoproteins, Lipoprotein,
Oxidation, and Atherogenesis, K.R. Chien, ed. (Philadelphia: W.B.
Saunders Co.).
41. Cyrus, T., Witztum, J.L., Rader, D.J., Tangirala, R., Fazio, S., Linton,
M.F., and Funk, C.D. (1999). Disruption of the 12/15-lipoxygenase
gene diminishes atherosclerosis in apo E-deficient mice. J. Clin.
Invest. 103, 1597—1604.
42. Harats, D., Shaish, A., George, J., Mulkins, M., Kurihara, H., Levko-
vitz, H., and Sigal, E. (2000). Overexpression of 15-Lipoxygenase in
Vascular Endothelium Accelerates Early Atherosclerosis in LDL
Receptor-Deficient Mice. Arterioscler. Thromb. Vasc. Biol. 20, 2100—
2105.
43. Knowles, J.W., Reddick, R.L., Jennette, J.C., Shesely, E.G., Smithies, O., and Maeda, N. (2000). Enhanced atherosclerosis and kidneydysfunction in eNOS(2/2)ApoE(2/2) mice are ameliorated by enalapriltreatment. J. Clin. Invest. 105, 451—458.
44. Cybulsky, M.I., and Gimbrone, M.A., Jr. (1991). Endothelial expres-
sion of a mononuclear leukocyte adhesion molecule during athero-
genesis. Science .251, 788—791.
45. Dong, Z., Chapman, S., Brown, A., Frenette, P., Hynes, R., and
Wagner, D. (1998). The Combined role of P- and E-selectins in ath-
erosclerosis. J. Clin. Invest. 102, 145—152.
46. Collins, R.G., Velji, R., Guevara, N.V., Hicks, M.J., Chan, L., and
Beaudet, A.L. (2000). P-selectin or intercellular adhesion molecule
(ICAM)-1 deficiency substantially protects against atherosclerosis
in apolipoprotein E—deficient mice. J. Exp. Med. 191, 189—194.
47. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum,J.L. (1989). Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320,915—924.
48. Han, K.H., Han, K.O., Green, S.R., and Quehenberger, O. (1999).
Expression of the monocyte chemoattractant protein-1 receptor
CCR2 is increased in hypercholesterolemia: differential effects of
plasma lipoproteins on monocyte function. J. Lipid Res. 40, 1053—
1063.
49. Gu, L., Okada, Y., Clinton, S.K., Gerard, C., Sukhova, G.K., Libby,
P., and Rollins, B.J. (1998). Absence of monocyte chemoattractant
protein-1 reduces atherosclerosis in low density lipoprotein-defi- rupcient mice. Mol. Cell 2, 275—281.
50. Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C.H., Young,
S.G., Rollins, B.J., and Charo, I.F. (1999). MCP-1 deficiency reduces
susceptibility to atherosclerosis in mice that overexpress human
apolipoprotein B. J. Clin. Invest. 103, 773—778.
51. Boring, L., Gosling, J., Cleary, M., and Charo, I.F. (1998). Decreased
lesion formation in CCR22/2 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894—897.
52. Qiao, J.H., Tripathi, J., Mishra, N.K., Cai, Y., Tripathi, S., Wang, X.P.,Imes, S., Fishbein, M.C., Clinton, S.K., Libby, P., Luis, A.J., and
Rajavashisth, T.B. (1997). Role of macrophage colony-stimulating
actor in atheroscleros is: studies of osteoporotic mice. Am. J. Path.
150, 1687—1699.
53.Yamada, Y., Doi, T., Hamakubo, T., and Kodama, T. (1998).Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. LifeSci.54,628—640.
54. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage,K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al.
(1997). A role for macrophage scavenger receptors in atherosclerosis
and susceptibility to infection. Nature 386, 292—296.
55.Colles, S.M., Irwin, K.C., and Chisolm, G.M. (1996). Roles of multiple oxidized lipids in cellular injury. J. Lipid Res. 37, 2018—2028.
56. Bennet, M.R. (1999). Apoptosis of vascular smooth muscle cells in
vascular remodelling and atherosclerotic plaque rupture.Cardiovascular Res. 41, 361—368.
57. Hansson, G.K. (1997). Cell-mediated immunity in atherosclerosis.
Curr Opin Lipidol 8, 301—311.
58. Davies, M.J., Richardson, P.D., and Woolf, N. (1993). Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart J. 69,
377—381.
59.Lee, R.T., and Libby, P. (1997). The unstable atheroma. Aterioscler.
Thromb. Vasc. Biol. 17, 1859—1867.
60.Havel, R. J., Eden, H. A., Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Inverst.34, 1345-1353.
61.Miura, S., Watanabe, J., Tomita, T., Sano, M., and Tomita, I. (1994). The inhibitory effects of tea polyphenol (flavon-3-ol derivativos) on Cu2+ mediated oxidative modification of LDL. Biol. Pharm. Bull.17,1567-1572.
62.Reid, V. C., Mitchinson, M. J. (1993) Toxicity of oxidized low-density lipoprotein towards mouse peritoneal macrophage in vivo. Atherosclerosis ,98, 17—24.
|